A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly diseases is starting human clinical testing.
In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
New York News on MSN
Beyond animal testing: Why human-relevant models are reshaping biomedical science
Animal models have long shaped how biomedical research is conducted. They have influenced how diseases are studied, how ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Austin startup that has been ...
Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...
In this week's "It's Debatable" segment, Rick Rosen and Charles Moster debate on the question: Should ethical/legal restrictions on human testing be lifted to expedite the development of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results